New Results
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
View ORCID ProfileKeiji Tanimoto, View ORCID ProfileKiichi Hirota, Takahiro Fukazawa, View ORCID ProfileYoshiyuki Matsuo, Toshihito Nomura, Nazmul Tanuza, Nobuyuki Hirohashi, View ORCID ProfileHidemasa Bono, Takemasa Sakaguchi
doi: https://doi.org/10.1101/2021.03.04.433658
Keiji Tanimoto
1Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan
Kiichi Hirota
2Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan
Takahiro Fukazawa
3Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan
Yoshiyuki Matsuo
2Department of Human Stress Response Science, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, Japan
Toshihito Nomura
4Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
Nazmul Tanuza
4Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
Nobuyuki Hirohashi
1Department of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan
Hidemasa Bono
5Program of Biomedical Science, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, 739-0046, Japan
Takemasa Sakaguchi
4Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
Article usage
Posted March 04, 2021.
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
Keiji Tanimoto, Kiichi Hirota, Takahiro Fukazawa, Yoshiyuki Matsuo, Toshihito Nomura, Nazmul Tanuza, Nobuyuki Hirohashi, Hidemasa Bono, Takemasa Sakaguchi
bioRxiv 2021.03.04.433658; doi: https://doi.org/10.1101/2021.03.04.433658
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
Keiji Tanimoto, Kiichi Hirota, Takahiro Fukazawa, Yoshiyuki Matsuo, Toshihito Nomura, Nazmul Tanuza, Nobuyuki Hirohashi, Hidemasa Bono, Takemasa Sakaguchi
bioRxiv 2021.03.04.433658; doi: https://doi.org/10.1101/2021.03.04.433658
Subject Area
Subject Areas
- Biochemistry (11562)
- Bioengineering (8622)
- Bioinformatics (28865)
- Biophysics (14793)
- Cancer Biology (11921)
- Cell Biology (17165)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12145)
- Genomics (16615)
- Immunology (11706)
- Microbiology (27690)
- Molecular Biology (11386)
- Neuroscience (60092)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3183)
- Physiology (4878)
- Plant Biology (10276)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1618)